Wound healing delay after central venous access following DCF/VEGF-trap therapy

Invest New Drugs. 2009 Dec;27(6):583-5. doi: 10.1007/s10637-009-9227-7. Epub 2009 Feb 17.

Abstract

Hypertension, proteinuria, thromboembolic or bleeding events are well-recognized complications occurring while targeting VEGF pathway. Wound healing dysfunctions have also been described in patients undergoing major surgery. For the first time, we report wound healing delay after central venous access following DCF-VEGF-Trap. VEGF-Trap may affect both angiogenesis and reepithelialization which are necessary to the normal repair process.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Central Venous Catheters / adverse effects*
  • Cisplatin / adverse effects*
  • Docetaxel
  • Fluorouracil / adverse effects*
  • Humans
  • Male
  • Receptors, Vascular Endothelial Growth Factor / adverse effects*
  • Recombinant Fusion Proteins / adverse effects*
  • Taxoids / adverse effects*
  • Wound Healing*

Substances

  • Recombinant Fusion Proteins
  • Taxoids
  • aflibercept
  • Docetaxel
  • Receptors, Vascular Endothelial Growth Factor
  • Cisplatin
  • Fluorouracil